Cargando…

More Attacks and Analgesic Use in Old Age: Self-Reported Headache Across the Lifespan in a German Sample

Background: Reliable population-based data on the prevalence and characteristics of primary headache across the lifespan are essential. However, robust data are lacking. Methods: We utilized questionnaire data from a random general population sample in Germany, that comprised 2,478 participants aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Britta, Dresler, Thomas, Gaul, Charly, Glass, Änne, Jürgens, Tim P., Kropp, Peter, Ruscheweyh, Ruth, Straube, Andreas, Förderreuther, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843053/
https://www.ncbi.nlm.nih.gov/pubmed/31749752
http://dx.doi.org/10.3389/fneur.2019.01000
_version_ 1783468127264178176
author Müller, Britta
Dresler, Thomas
Gaul, Charly
Glass, Änne
Jürgens, Tim P.
Kropp, Peter
Ruscheweyh, Ruth
Straube, Andreas
Förderreuther, Stefanie
author_facet Müller, Britta
Dresler, Thomas
Gaul, Charly
Glass, Änne
Jürgens, Tim P.
Kropp, Peter
Ruscheweyh, Ruth
Straube, Andreas
Förderreuther, Stefanie
author_sort Müller, Britta
collection PubMed
description Background: Reliable population-based data on the prevalence and characteristics of primary headache across the lifespan are essential. However, robust data are lacking. Methods: We utilized questionnaire data from a random general population sample in Germany, that comprised 2,478 participants aged ≥14 years. A standardized questionnaire addressing headache and headache treatment was filled in during the face-to-face survey. Results: The 6-month prevalence of self-reported headache in the total sample amounted to 39.0% (known diagnosis of migraine 7.2%; tension-type headache 12.4%; another diagnosis or unknown diagnosis 23.4%). Age-specific prevalence rates were 37.9% (14–34 years), 44.6% (35–54 years), 38.5% (55–74 years), and 26.9% (≥75 years). Compared to age group 14–34, participants aged 35–54 were more (OR = 1.29, 95%-CI 1.05–1.60, p = 0.018) and those aged ≥75 were less (OR = 0.55, 95%-CI 0.40–0.76, p < 0.001) likely to have any headache. Of the participants with headache, 79.5% reported headache on <4 days per month, 15.6% on 4–14 days per month and 4.9% on >14 days per month. The frequency of headache did not differ significantly between age groups in men [[Formula: see text] = 1.45, p > 0.05], but in women [[Formula: see text] = 21.57, p < 0.001]: women aged ≥75 years were over-represented in the group reporting 4–14 headache days per month. The analgesic use (days per month) differed significantly between age groups among participants with headache on <4 days per month and on >14 days per month: 1.8 (14–34 years), 2.5 (35–54 years), 3.2 (55–74 years), and 3.4 (≥75 years), respectively 7.9 (14–34 years), 11.4 (35–54 years), 18.4 (55–74 years), and 22.8 (≥75 years). Conclusions: In general, the prevalence of headache decreases with age. However, older women suffer from more frequent attacks and older participants take analgesics on more days per month than younger participants. This might put them at risk of medication overuse which may lead to medication overuse headache. More research is needed to understand these specifics in headache frequency and treatment behavior in older people.
format Online
Article
Text
id pubmed-6843053
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68430532019-11-20 More Attacks and Analgesic Use in Old Age: Self-Reported Headache Across the Lifespan in a German Sample Müller, Britta Dresler, Thomas Gaul, Charly Glass, Änne Jürgens, Tim P. Kropp, Peter Ruscheweyh, Ruth Straube, Andreas Förderreuther, Stefanie Front Neurol Neurology Background: Reliable population-based data on the prevalence and characteristics of primary headache across the lifespan are essential. However, robust data are lacking. Methods: We utilized questionnaire data from a random general population sample in Germany, that comprised 2,478 participants aged ≥14 years. A standardized questionnaire addressing headache and headache treatment was filled in during the face-to-face survey. Results: The 6-month prevalence of self-reported headache in the total sample amounted to 39.0% (known diagnosis of migraine 7.2%; tension-type headache 12.4%; another diagnosis or unknown diagnosis 23.4%). Age-specific prevalence rates were 37.9% (14–34 years), 44.6% (35–54 years), 38.5% (55–74 years), and 26.9% (≥75 years). Compared to age group 14–34, participants aged 35–54 were more (OR = 1.29, 95%-CI 1.05–1.60, p = 0.018) and those aged ≥75 were less (OR = 0.55, 95%-CI 0.40–0.76, p < 0.001) likely to have any headache. Of the participants with headache, 79.5% reported headache on <4 days per month, 15.6% on 4–14 days per month and 4.9% on >14 days per month. The frequency of headache did not differ significantly between age groups in men [[Formula: see text] = 1.45, p > 0.05], but in women [[Formula: see text] = 21.57, p < 0.001]: women aged ≥75 years were over-represented in the group reporting 4–14 headache days per month. The analgesic use (days per month) differed significantly between age groups among participants with headache on <4 days per month and on >14 days per month: 1.8 (14–34 years), 2.5 (35–54 years), 3.2 (55–74 years), and 3.4 (≥75 years), respectively 7.9 (14–34 years), 11.4 (35–54 years), 18.4 (55–74 years), and 22.8 (≥75 years). Conclusions: In general, the prevalence of headache decreases with age. However, older women suffer from more frequent attacks and older participants take analgesics on more days per month than younger participants. This might put them at risk of medication overuse which may lead to medication overuse headache. More research is needed to understand these specifics in headache frequency and treatment behavior in older people. Frontiers Media S.A. 2019-10-17 /pmc/articles/PMC6843053/ /pubmed/31749752 http://dx.doi.org/10.3389/fneur.2019.01000 Text en Copyright © 2019 Müller, Dresler, Gaul, Glass, Jürgens, Kropp, Ruscheweyh, Straube and Förderreuther. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Müller, Britta
Dresler, Thomas
Gaul, Charly
Glass, Änne
Jürgens, Tim P.
Kropp, Peter
Ruscheweyh, Ruth
Straube, Andreas
Förderreuther, Stefanie
More Attacks and Analgesic Use in Old Age: Self-Reported Headache Across the Lifespan in a German Sample
title More Attacks and Analgesic Use in Old Age: Self-Reported Headache Across the Lifespan in a German Sample
title_full More Attacks and Analgesic Use in Old Age: Self-Reported Headache Across the Lifespan in a German Sample
title_fullStr More Attacks and Analgesic Use in Old Age: Self-Reported Headache Across the Lifespan in a German Sample
title_full_unstemmed More Attacks and Analgesic Use in Old Age: Self-Reported Headache Across the Lifespan in a German Sample
title_short More Attacks and Analgesic Use in Old Age: Self-Reported Headache Across the Lifespan in a German Sample
title_sort more attacks and analgesic use in old age: self-reported headache across the lifespan in a german sample
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843053/
https://www.ncbi.nlm.nih.gov/pubmed/31749752
http://dx.doi.org/10.3389/fneur.2019.01000
work_keys_str_mv AT mullerbritta moreattacksandanalgesicuseinoldageselfreportedheadacheacrossthelifespaninagermansample
AT dreslerthomas moreattacksandanalgesicuseinoldageselfreportedheadacheacrossthelifespaninagermansample
AT gaulcharly moreattacksandanalgesicuseinoldageselfreportedheadacheacrossthelifespaninagermansample
AT glassanne moreattacksandanalgesicuseinoldageselfreportedheadacheacrossthelifespaninagermansample
AT jurgenstimp moreattacksandanalgesicuseinoldageselfreportedheadacheacrossthelifespaninagermansample
AT kropppeter moreattacksandanalgesicuseinoldageselfreportedheadacheacrossthelifespaninagermansample
AT ruscheweyhruth moreattacksandanalgesicuseinoldageselfreportedheadacheacrossthelifespaninagermansample
AT straubeandreas moreattacksandanalgesicuseinoldageselfreportedheadacheacrossthelifespaninagermansample
AT forderreutherstefanie moreattacksandanalgesicuseinoldageselfreportedheadacheacrossthelifespaninagermansample